US20060235464A1 - Aneurysm embolic device with an occlusive member - Google Patents

Aneurysm embolic device with an occlusive member Download PDF

Info

Publication number
US20060235464A1
US20060235464A1 US11/452,852 US45285206A US2006235464A1 US 20060235464 A1 US20060235464 A1 US 20060235464A1 US 45285206 A US45285206 A US 45285206A US 2006235464 A1 US2006235464 A1 US 2006235464A1
Authority
US
United States
Prior art keywords
aneurysm
sealing member
catheter
occlusive
embolic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/452,852
Inventor
Ernesto Avellanet
Robert Lulo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DePuy Spine LLC
DePuy Synthes Products Inc
Original Assignee
Ernesto Avellanet
Robert Lulo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ernesto Avellanet, Robert Lulo filed Critical Ernesto Avellanet
Priority to US11/452,852 priority Critical patent/US20060235464A1/en
Publication of US20060235464A1 publication Critical patent/US20060235464A1/en
Assigned to CODMAN & SHURTLEFF, INC. reassignment CODMAN & SHURTLEFF, INC. MERGER (SEE DOCUMENT FOR DETAILS). Assignors: CORDIS NEUROVASCULAR, INC.
Assigned to DEPUY SPINE, INC. reassignment DEPUY SPINE, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CODMAN & SHURTLEFF, INC.
Assigned to HAND INNOVATIONS LLC reassignment HAND INNOVATIONS LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DEPUY SPINE, LLC
Assigned to DePuy Synthes Products, LLC reassignment DePuy Synthes Products, LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: HAND INNOVATIONS LLC
Assigned to DEPUY SPINE, LLC reassignment DEPUY SPINE, LLC CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME PREVIOUSLY RECORDED AT REEL: 030341 FRAME: 0689. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Assignors: CODMAN & SHURTLEFF, INC.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A61B17/1219—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices expandable in contact with liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00535—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated
    • A61B2017/00539—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated hydraulically
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205—Introduction devices

Definitions

  • This invention relates to catheter-based implantable medical devices for occluding the flow of blood at a preselected position within a blood vessel, and more particularly to an aneurysm embolic device which serves to fill an aneurysm with an occlusive member thereby preventing the flow of blood into the aneurysm.
  • Aneurysms typically take the form of a balloon-like swelling in the wall of a vessel which generally results from a weakness in the vessel wall. If untreated, aneurysms may continue expanding until they burst thereby causing hemorrhaging to occur. If, for example, an aneurysm is present within an artery of the brain, and the aneurysm should burst with resulting cranial hemorrhaging, death could occur.
  • Aneurysms result from many different causes; however, most aneurysms are caused as a result of a degenerative disease which damages the muscular coating of a vessel with resulting congenital deficiency in the muscular wall of the vessel.
  • stents are expanded to the proper size by inflating a balloon catheter, referred to as balloon expandable stents, while other stents are designed to elastically expand in a self-expanding manner.
  • Balloon expandable stents and self-expanding stents are generally delivered to a preselected position through a delivery catheter. They are moved out of the distal end of the delivery catheter, are expanded and then are released to remain within the vessel.
  • a delivery catheter system which may be used to place a stent within a vessel is disclosed in U.S. Pat. No. 6,254,612 entitled, “Hydraulic Stent Deployment System” and assigned to the same assignee as the present patent application.
  • the stent deployment system disclosed in this patent which is incorporated herein by reference, includes a deployment catheter having a distal tip for retaining a stent in order to transport the stent to a preselected position within the vessel. Once the stent has been properly positioned, a hydraulic control mechanism is used to release the stent from the distal end of the catheter and deposit the stent at the preselected location within the vessel.
  • Another method for treating aneurysms is that of using a microcatheter for placing multiple very small embolic coils within the aneurysm with the expectation that fibrous material will become entrapped in the embolic coils to thereby stabilize the coils within the aneurysm.
  • embolic coils With this technique, it is possible to fill the aneurysm with embolic coils thereby sealing off the walls of the aneurysm from the pressure of blood which exist in the adjacent vessel.
  • One modification to the technique of placing embolic coils within an aneurysm is that of using a stent or scaffold like structure which is placed across the aneurysm by having passageways within the structures so that embolic coils may be passed through the structure and into the aneurysm.
  • the stent, or scaffold like structure serves to hold the embolic coils within the stent until such time as these coils become stabilized by fibrous material growing into the coils.
  • One example of such a structure, or stent, for use in this form of treatment of an aneurysm is disclosed in U.S. Pat. No. 6,063,111 entitled, “Stent Aneurysm Treatment System And Method.”
  • Still another method of treating an aneurysm, and in particular an aneurysm within the brain is that of placing a mesh covered support structure within the aneurysm itself and subsequently expanding the mesh covered structure in order to fill the entire aneurysm.
  • a mesh covered support structure serves to fill the aneurysm and thereby prevent blood flowing in an adjacent vessel from entering the aneurysm.
  • These devices referred to as occlusion devices, serve to prevent the pressure of blood flowing through a vessel from being applied to the walls of the aneurysm thereby preventing, or reducing, the further expansion of the aneurysm.
  • a catheter-based aneurysm embolic system for occluding the flow of blood into an aneurysm.
  • the aneurysm embolic system includes a deployment catheter.
  • the embolic system also includes an introducer sheath which is disposed about the deployment catheter.
  • the embolic system further includes an aneurysm embolic device which includes an expandable sealing member and an occlusive member which takes the form of an expandable foam material.
  • the sealing member is preferably an expandable flexible disk and is comprised of a circular joining member located at the center of the sealing member.
  • a plurality of reinforcing spokes are attached to the circular joining member and extend radially outward from the circular joining member.
  • a thin circular membrane is bonded to the circular joining member and the reinforcing spokes, and an occlusive member, such as an expandable foam, is carried by the sealing member.
  • a headpiece is attached to the center of the sealing member and is disposed in the distal end of the deployment catheter.
  • the sealing member When the aneurysm embolic device is placed at the neck of an aneurysm the sealing member may be expanded to seal the mouth of the aneurysm and simultaneously permit deployment of the occlusive member within the aneurysm to substantially fill the aneurysm.
  • the occlusive member is formed of a material such that when the sealing member is deployed within an aneurysm the occlusive member may be released within the aneurysm and the material expands to substantially fill the aneurysm.
  • the aneurysm embolic device includes first and second circular membranes having surfaces which are bonded together and which encapsulate the circular joining member and the reinforcing spokes.
  • the circular membrane is preferably made from a blood-impermeable polymer material.
  • the expandable sealing member is slightly cupped to form convex and concave sides.
  • the occlusive member is attached to the concave side of the sealing member.
  • the expandable sealing member is tubular shaped when the sealing member is disposed within the lumen of the sheath.
  • FIG. 1 is an enlarged perspective view of an aneurysm embolic device, a deployment catheter, and a sheath in accordance with the present invention
  • FIG. 2 is an enlarged, sectional view of the aneurysm embolic device in a compressed configuration within a lumen of the sheath and attached to a distal end of the deployment catheter;
  • FIG. 3 is an enlarged, perspective view of the aneurysm embolic device in a deployed configuration showing an expanded occlusive member
  • FIG. 3 a is an enlarged, perspective view of the aneurysm embolic device as viewed from a distal end of the deployment catheter;
  • FIG. 3 b is an enlarged, cross sectional view of the aneurysm embolic device showing reinforcing spokes encapsulated between two thin circular membranes and the expanded occlusive member disposed on the circular membranes;
  • FIG. 4 is an enlarged, sectional view of the aneurysm embolic device in its compressed configuration being positioned over an aneurysm;
  • FIG. 5 is an enlarged, sectional view of the aneurysm embolic device being deployed within the aneurysm
  • FIG. 6 is an enlarged, sectional view of the aneurysm embolic device in its deployed configuration with the occlusive member substantially filling the aneurysm.
  • FIG. 1 illustrates an aneurysm embolic device 10 , a deployment catheter 12 , and a sheath 14 in accordance with the present invention.
  • the deployment catheter 12 is an elongated tube with a lumen 16 .
  • the proximal section 18 of the deployment catheter 12 is formed of a pellethane material having a durometer in a range of about 60 D to 75 D.
  • the proximal section 18 is sufficiently flexible to transverse the vasculature of the human body, but is sufficiently rigid so that it can be pushed distally through the sheath 14 .
  • the distal section 20 of the deployment catheter 12 is preferably formed of a pellethane material having a durometer of between 25 D and 55 D with a durometer of 40 D being the preferred durometer.
  • the deployment catheter 12 also includes a winged hub 22 coupled to the proximal section 18 of the deployment catheter 12 .
  • the winged hub 22 may be made from plastic and aids in the insertion of the deployment catheter 12 into the vasculature of the body.
  • the sheath 14 is also an elongated tube with a lumen 24 extending therethrough.
  • the sheath 14 is preferably formed of a polymer material and is sufficiently flexible to transverse the vasculature of the body.
  • the deployment catheter 12 and aneurysm embolic device 10 are disposed within the lumen 24 of the sheath 14 .
  • the diameter of the lumen 24 on the sheath 14 is sufficiently small enough so that the aneurysm embolic device 10 is forced to a compressed configuration.
  • the aneurysm embolic device 10 is attached to the distal end 26 of the deployment catheter 12 by way of a headpiece 28 which is described in more detail below.
  • FIG. 2 illustrates the aneurysm embolic device 10 in a compressed configuration within the lumen 24 of the sheath 14 .
  • the aneurysm embolic device 10 includes an expandable sealing member 30 . When compressed, the expandable sealing member 30 is generally tube-shaped such that the aneurysm embolic device 10 may be disposed within a sheath 14 .
  • the aneurysm embolic device 10 also includes a plurality of longitudinal reinforcing spokes 32 within the expandable sealing member 30 . These reinforcing spokes 32 are discussed in the description of FIG. 3 a .
  • the headpiece 28 is attached to the sealing member 30 and is disposed within the distal end 26 of the deployment catheter 12 . The headpiece 28 forms a fluid tight seal in the distal end 26 of the deployment catheter 12 so that when a fluid pressure is applied to the lumen 16 of the deployment catheter 12 , the headpiece 28 is released from the distal end 26 of the deployment catheter 12 .
  • FIG. 3 illustrates the aneurysm embolic device 10 in a deployed configuration.
  • the expandable sealing member 30 is preferably made of a flexible material like a polymer, silicon, or fabric, but may also be formed from a metallic material such as platinum or Nitinol.
  • the expandable sealing member 30 may also include radiopaque material for fluoroscopic visualization.
  • the sealing member 30 is slightly cupped so that when the sealing member 30 is deployed within an aneurysm, the convex side 36 of the sealing member 30 conforms to a wall of the aneurysm.
  • the diameter of the sealing member 30 is preferably slightly larger than the diameter of an opening of the aneurysm 34 .
  • the sealing member 30 will seal the opening of a 5 to 6 mm aneurysm, but may be increased in size to seal aneurysms in the range of 3 to 20 mm.
  • the occlusive member 38 is compressed when the aneurysm embolic device 10 is disposed within the lumen 24 of the sheath 14 .
  • the occlusive member 38 is released into an aneurysm 34 as illustrated in FIG. 5 .
  • the sealing member 30 occludes the mouth of the aneurysm 34 and prevents the occlusive member 38 from exiting the aneurysm 34 .
  • the occlusive member 38 is preferably polyvinyl alcohol, but may also be nylon fibers, biocompatible foam, biocompatible adhesive, embolic coils, or an expandable material, such as for example, hydrogel.
  • the convex side 36 of the sealing member 30 forms a generally fluid tight seal around the interior opening of the aneurysm 34 .
  • the occlusive member 38 may be anchored to the aneurysm embolic device 10 or preferably may rest freely within the compressed aneurysm embolic device 10 until deployed.
  • FIG. 3 a illustrates the aneurysm embolic device 10 in a deployed configuration as viewed from within a blood vessel adjacent to the aneurysm 34 .
  • a thin circular joining member 44 is disposed at the center 46 of the sealing member 30 .
  • the circular joining member 44 may be made of stainless steel, titanium, platinum, or a polymer material, but the preferred material is Nitinol.
  • a plurality of reinforcing spokes 32 extends radially outward from the circular joining member 44 .
  • the proximal ends 48 of each reinforcing spoke are attached to the circular joining member 44 , while the distal ends 50 of each reinforcing spoke 32 extend generally to the outer edge 52 of the sealing member 30 .
  • the reinforcing spokes 32 may be made of the same material as the circular joining member 44 .
  • the reinforcing spokes 32 may take the form of cylindrical rods, flat battens, or rectangular rods.
  • the circular joining member 44 and the reinforcing spokes 32 are one unitary structure laser cut from Nitinol.
  • the headpiece 28 may also be cut from the same unitary Nitinol structure.
  • the circular joining member 44 and the reinforcing spokes 32 may include radiopaque markers for use during fluoroscopic visualization.
  • FIG. 3 b illustrates the slightly cupped configuration of the expandable sealing member 30 .
  • the curvature may be created by a normally curved sealing member 30 , but preferably, the curvature is formed by normally curved reinforcing spokes 32 .
  • Two thin circular membranes 54 are bonded to the reinforcing spokes 32 and the circular joining member 44 (not shown).
  • one circular membrane 54 may be attached to the reinforcing spokes 32 on the concave side 40 of the sealing member 30 while the other circular membrane 54 may be attached to the reinforcing spokes 32 on the convex side 36 of the sealing member 30 , such that the circular membranes 54 encapsulate the reinforcing spokes 32 and the circular joining member 44 .
  • the occlusive member 38 is disposed on the concave side 40 of the expandable sealing member 30 .
  • FIGS. 4 through 6 illustrate the deployment of the aneurysm embolic device 10 within the aneurysm 34 .
  • FIG. 4 illustrates the aneurysm embolic device 10 , the deployment catheter 12 , and sheath 14 being positioned within the blood vessel 42 adjacent to the aneurysm 34 to be treated.
  • the headpiece 28 of the aneurysm embolic device 10 is disposed within the lumen 16 of the deployment catheter 12
  • the aneurysm embolic device 10 is disposed within the sheath 14 so that the sealing member 30 is in a compressed configuration. This allows the aneurysm embolic device 10 to hold the occlusive member 38 and to be transported through the narrow vasculature.
  • a delivery catheter 56 is positioned within the vasculature to guide the deployment catheter 12 to the preselected aneurysm 34 and to protect the vasculature from damage or puncture.
  • FIG. 5 illustrates the distal end 58 of the sheath 14 being positioned at the mouth of the aneurysm 34 .
  • the deployment catheter 12 is moved distally causing the sealing member 30 of the aneurysm embolic device 10 to exit the lumen 24 of the sheath 14 .
  • the sealing member 30 and occlusive member 38 expand within the aneurysm 34 .
  • the thin circular membranes 54 of the sealing member 30 contact the wall of the aneurysm 34 and form a generally fluid tight seal.
  • FIG. 6 illustrates fluid pressure being applied to the lumen 16 of the deployment catheter 12 thereby causing the headpiece 28 of the aneurysm embolic device 10 to exit the distal end 26 of the deployment catheter 12 .
  • the expanded occlusive member 38 holds the sealing member 30 in position, and blood is generally prevented from flowing into the aneurysm 34 .
  • an aneurysm embolic device is used to occlude the flow of blood within an aneurysm.
  • a preferred embodiment of the invention has been described, it is to be understood that various modifications may be made by those skilled in the art without departing from the scope of the present invention.
  • the occlusive member including helically wound embolic coils or other types of vascular occlusive devices, such as balloons, radiopaque fluids, and liquid medications.

Abstract

An aneurysm embolic device is disclosed for use in occluding the flow of blood within an aneurysm. The aneurysm embolic device includes an expandable sealing member having a circular joining member and reinforcing spokes which give the sealing member a slightly cupped configuration. The embolic device also includes an occlusive member carried by the expandable sealing member. When the aneurysm embolic device is deployed within the aneurysm, the sealing member expands and the occlusive member fills the aneurysm preventing the flow of blood within the aneurysm.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS(S)
  • This patent application is a divisional patent application of U.S. patent application Ser. No. 10/295,196 (Attorney Docket No. CRD0980USNP), filed on Nov. 15, 2002, entitled, “Aneurysm Embolic Device With An Occlusive Member,” which is a nonprovisional patent application of U.S. provisional patent application Ser. No. 60/335,489, filed on Nov. 15, 2001.
    • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • This invention relates to catheter-based implantable medical devices for occluding the flow of blood at a preselected position within a blood vessel, and more particularly to an aneurysm embolic device which serves to fill an aneurysm with an occlusive member thereby preventing the flow of blood into the aneurysm.
  • 2. Description of the Prior Art
  • Aneurysms typically take the form of a balloon-like swelling in the wall of a vessel which generally results from a weakness in the vessel wall. If untreated, aneurysms may continue expanding until they burst thereby causing hemorrhaging to occur. If, for example, an aneurysm is present within an artery of the brain, and the aneurysm should burst with resulting cranial hemorrhaging, death could occur.
  • Aneurysms result from many different causes; however, most aneurysms are caused as a result of a degenerative disease which damages the muscular coating of a vessel with resulting congenital deficiency in the muscular wall of the vessel.
  • Various attempts have been made to treat aneurysms without resorting to surgery, such as the placement of sleeves or stents into the vessel and across the region where the aneurysm occurs. Such devices maintain blood flow through the vessel while reducing blood pressure applied to the interior of the aneurysm. Certain types of stents are expanded to the proper size by inflating a balloon catheter, referred to as balloon expandable stents, while other stents are designed to elastically expand in a self-expanding manner. Balloon expandable stents and self-expanding stents are generally delivered to a preselected position through a delivery catheter. They are moved out of the distal end of the delivery catheter, are expanded and then are released to remain within the vessel. One example of a delivery catheter system which may be used to place a stent within a vessel is disclosed in U.S. Pat. No. 6,254,612 entitled, “Hydraulic Stent Deployment System” and assigned to the same assignee as the present patent application. The stent deployment system disclosed in this patent, which is incorporated herein by reference, includes a deployment catheter having a distal tip for retaining a stent in order to transport the stent to a preselected position within the vessel. Once the stent has been properly positioned, a hydraulic control mechanism is used to release the stent from the distal end of the catheter and deposit the stent at the preselected location within the vessel.
  • Another method for treating aneurysms, particularly where the aneurysm occurs in a very small vessel of the brain, is that of using a microcatheter for placing multiple very small embolic coils within the aneurysm with the expectation that fibrous material will become entrapped in the embolic coils to thereby stabilize the coils within the aneurysm. With this technique, it is possible to fill the aneurysm with embolic coils thereby sealing off the walls of the aneurysm from the pressure of blood which exist in the adjacent vessel.
  • Examples of a catheter deployment system for depositing embolic coils into an aneurysm are disclosed in U.S. Pat. No. 6,063,100, entitled, “Embolic Coil Deployment System With Improved Embolic Coil”; U.S. Pat. No. 6,183,491 entitled, “Embolic Coil Deployment System With Improved Embolic Coil”; and U.S. Pat. No. 6,113,622 entitled, “Embolic Coil Hydraulic Deployment System,” all of which are assigned to the assignee of the present patent application. These patents, and the disclosure thereof, are incorporated herein by reference and made a part of the present patent application.
  • One modification to the technique of placing embolic coils within an aneurysm is that of using a stent or scaffold like structure which is placed across the aneurysm by having passageways within the structures so that embolic coils may be passed through the structure and into the aneurysm. The stent, or scaffold like structure, serves to hold the embolic coils within the stent until such time as these coils become stabilized by fibrous material growing into the coils. One example of such a structure, or stent, for use in this form of treatment of an aneurysm is disclosed in U.S. Pat. No. 6,063,111 entitled, “Stent Aneurysm Treatment System And Method.”
  • Still another method of treating an aneurysm, and in particular an aneurysm within the brain, is that of placing a mesh covered support structure within the aneurysm itself and subsequently expanding the mesh covered structure in order to fill the entire aneurysm. Such a structure serves to fill the aneurysm and thereby prevent blood flowing in an adjacent vessel from entering the aneurysm. These devices, referred to as occlusion devices, serve to prevent the pressure of blood flowing through a vessel from being applied to the walls of the aneurysm thereby preventing, or reducing, the further expansion of the aneurysm.
  • One such aneurysm occlusion or embolization device is disclosed in U.S. patent application Ser. No. 09/505,231 entitled, “Aneurysm Embolization Device,” and assigned to the same assignee as the present patent application.
  • Even with the existing treatment techniques for aneurysms, and in particular for aneurysm which exists within the brain, there is a need for other forms of aneurysm treatment that may be easily delivered to a vascular site through a very small catheter, and in particular for a device which serves to seal off the flow of blood between an adjacent vessel and an aneurysm.
    • SUMMARY OF THE INVENTION
  • In accordance with one aspect of the present invention, there is provided a catheter-based aneurysm embolic system for occluding the flow of blood into an aneurysm. The aneurysm embolic system includes a deployment catheter. The embolic system also includes an introducer sheath which is disposed about the deployment catheter. The embolic system further includes an aneurysm embolic device which includes an expandable sealing member and an occlusive member which takes the form of an expandable foam material.
  • The sealing member is preferably an expandable flexible disk and is comprised of a circular joining member located at the center of the sealing member. A plurality of reinforcing spokes are attached to the circular joining member and extend radially outward from the circular joining member. A thin circular membrane is bonded to the circular joining member and the reinforcing spokes, and an occlusive member, such as an expandable foam, is carried by the sealing member. In addition, a headpiece is attached to the center of the sealing member and is disposed in the distal end of the deployment catheter. When the aneurysm embolic device is placed at the neck of an aneurysm the sealing member may be expanded to seal the mouth of the aneurysm and simultaneously permit deployment of the occlusive member within the aneurysm to substantially fill the aneurysm.
  • In accordance with another aspect of the present invention, the occlusive member is formed of a material such that when the sealing member is deployed within an aneurysm the occlusive member may be released within the aneurysm and the material expands to substantially fill the aneurysm.
  • In accordance with a further aspect of the present invention, the aneurysm embolic device includes first and second circular membranes having surfaces which are bonded together and which encapsulate the circular joining member and the reinforcing spokes. The circular membrane is preferably made from a blood-impermeable polymer material.
  • In accordance with still another aspect of the present invention, the expandable sealing member is slightly cupped to form convex and concave sides. The occlusive member is attached to the concave side of the sealing member.
  • In accordance with another aspect of the present invention, the expandable sealing member is tubular shaped when the sealing member is disposed within the lumen of the sheath.
    • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is an enlarged perspective view of an aneurysm embolic device, a deployment catheter, and a sheath in accordance with the present invention;
  • FIG. 2 is an enlarged, sectional view of the aneurysm embolic device in a compressed configuration within a lumen of the sheath and attached to a distal end of the deployment catheter;
  • FIG. 3 is an enlarged, perspective view of the aneurysm embolic device in a deployed configuration showing an expanded occlusive member;
  • FIG. 3 a is an enlarged, perspective view of the aneurysm embolic device as viewed from a distal end of the deployment catheter;
  • FIG. 3 b is an enlarged, cross sectional view of the aneurysm embolic device showing reinforcing spokes encapsulated between two thin circular membranes and the expanded occlusive member disposed on the circular membranes;
  • FIG. 4 is an enlarged, sectional view of the aneurysm embolic device in its compressed configuration being positioned over an aneurysm;
  • FIG. 5 is an enlarged, sectional view of the aneurysm embolic device being deployed within the aneurysm; and,
  • FIG. 6 is an enlarged, sectional view of the aneurysm embolic device in its deployed configuration with the occlusive member substantially filling the aneurysm.
    • DESCRIPTION OF THE PREFERRED EMBODIMENT
  • FIG. 1 illustrates an aneurysm embolic device 10, a deployment catheter 12, and a sheath 14 in accordance with the present invention. The deployment catheter 12 is an elongated tube with a lumen 16. Preferably, the proximal section 18 of the deployment catheter 12 is formed of a pellethane material having a durometer in a range of about 60 D to 75 D. The proximal section 18 is sufficiently flexible to transverse the vasculature of the human body, but is sufficiently rigid so that it can be pushed distally through the sheath 14. The distal section 20 of the deployment catheter 12 is preferably formed of a pellethane material having a durometer of between 25 D and 55 D with a durometer of 40 D being the preferred durometer.
  • The deployment catheter 12 also includes a winged hub 22 coupled to the proximal section 18 of the deployment catheter 12. The winged hub 22 may be made from plastic and aids in the insertion of the deployment catheter 12 into the vasculature of the body. The sheath 14 is also an elongated tube with a lumen 24 extending therethrough. The sheath 14 is preferably formed of a polymer material and is sufficiently flexible to transverse the vasculature of the body. The deployment catheter 12 and aneurysm embolic device 10 are disposed within the lumen 24 of the sheath 14. The diameter of the lumen 24 on the sheath 14 is sufficiently small enough so that the aneurysm embolic device 10 is forced to a compressed configuration. The aneurysm embolic device 10 is attached to the distal end 26 of the deployment catheter 12 by way of a headpiece 28 which is described in more detail below.
  • FIG. 2 illustrates the aneurysm embolic device 10 in a compressed configuration within the lumen 24 of the sheath 14. The aneurysm embolic device 10 includes an expandable sealing member 30. When compressed, the expandable sealing member 30 is generally tube-shaped such that the aneurysm embolic device 10 may be disposed within a sheath 14. The aneurysm embolic device 10 also includes a plurality of longitudinal reinforcing spokes 32 within the expandable sealing member 30. These reinforcing spokes 32 are discussed in the description of FIG. 3 a. The headpiece 28 is attached to the sealing member 30 and is disposed within the distal end 26 of the deployment catheter 12. The headpiece 28 forms a fluid tight seal in the distal end 26 of the deployment catheter 12 so that when a fluid pressure is applied to the lumen 16 of the deployment catheter 12, the headpiece 28 is released from the distal end 26 of the deployment catheter 12.
  • FIG. 3 illustrates the aneurysm embolic device 10 in a deployed configuration. The expandable sealing member 30 is preferably made of a flexible material like a polymer, silicon, or fabric, but may also be formed from a metallic material such as platinum or Nitinol. The expandable sealing member 30 may also include radiopaque material for fluoroscopic visualization. Preferably, the sealing member 30 is slightly cupped so that when the sealing member 30 is deployed within an aneurysm, the convex side 36 of the sealing member 30 conforms to a wall of the aneurysm. The diameter of the sealing member 30 is preferably slightly larger than the diameter of an opening of the aneurysm 34. Typically, the sealing member 30 will seal the opening of a 5 to 6 mm aneurysm, but may be increased in size to seal aneurysms in the range of 3 to 20 mm.
  • The occlusive member 38 is compressed when the aneurysm embolic device 10 is disposed within the lumen 24 of the sheath 14. When the aneurysm embolic device 10 is deployed, the occlusive member 38 is released into an aneurysm 34 as illustrated in FIG. 5. The sealing member 30 occludes the mouth of the aneurysm 34 and prevents the occlusive member 38 from exiting the aneurysm 34. The occlusive member 38 is preferably polyvinyl alcohol, but may also be nylon fibers, biocompatible foam, biocompatible adhesive, embolic coils, or an expandable material, such as for example, hydrogel. As the occlusive member 38 is deployed within the aneurysm 34, the convex side 36 of the sealing member 30 forms a generally fluid tight seal around the interior opening of the aneurysm 34. The occlusive member 38 may be anchored to the aneurysm embolic device 10 or preferably may rest freely within the compressed aneurysm embolic device 10 until deployed.
  • FIG. 3 a illustrates the aneurysm embolic device 10 in a deployed configuration as viewed from within a blood vessel adjacent to the aneurysm 34. A thin circular joining member 44 is disposed at the center 46 of the sealing member 30. The circular joining member 44 may be made of stainless steel, titanium, platinum, or a polymer material, but the preferred material is Nitinol. A plurality of reinforcing spokes 32 extends radially outward from the circular joining member 44. The proximal ends 48 of each reinforcing spoke are attached to the circular joining member 44, while the distal ends 50 of each reinforcing spoke 32 extend generally to the outer edge 52 of the sealing member 30.
  • Preferably, the reinforcing spokes 32 may be made of the same material as the circular joining member 44. The reinforcing spokes 32 may take the form of cylindrical rods, flat battens, or rectangular rods. Preferably, the circular joining member 44 and the reinforcing spokes 32 are one unitary structure laser cut from Nitinol. The headpiece 28 may also be cut from the same unitary Nitinol structure. The circular joining member 44 and the reinforcing spokes 32 may include radiopaque markers for use during fluoroscopic visualization.
  • FIG. 3 b illustrates the slightly cupped configuration of the expandable sealing member 30. The curvature may be created by a normally curved sealing member 30, but preferably, the curvature is formed by normally curved reinforcing spokes 32. Two thin circular membranes 54 are bonded to the reinforcing spokes 32 and the circular joining member 44 (not shown). Preferably, one circular membrane 54 may be attached to the reinforcing spokes 32 on the concave side 40 of the sealing member 30 while the other circular membrane 54 may be attached to the reinforcing spokes 32 on the convex side 36 of the sealing member 30, such that the circular membranes 54 encapsulate the reinforcing spokes 32 and the circular joining member 44. The occlusive member 38 is disposed on the concave side 40 of the expandable sealing member 30.
  • FIGS. 4 through 6 illustrate the deployment of the aneurysm embolic device 10 within the aneurysm 34. FIG. 4 illustrates the aneurysm embolic device 10, the deployment catheter 12, and sheath 14 being positioned within the blood vessel 42 adjacent to the aneurysm 34 to be treated. The headpiece 28 of the aneurysm embolic device 10 is disposed within the lumen 16 of the deployment catheter 12, and the aneurysm embolic device 10 is disposed within the sheath 14 so that the sealing member 30 is in a compressed configuration. This allows the aneurysm embolic device 10 to hold the occlusive member 38 and to be transported through the narrow vasculature. A delivery catheter 56 is positioned within the vasculature to guide the deployment catheter 12 to the preselected aneurysm 34 and to protect the vasculature from damage or puncture.
  • FIG. 5 illustrates the distal end 58 of the sheath 14 being positioned at the mouth of the aneurysm 34. The deployment catheter 12 is moved distally causing the sealing member 30 of the aneurysm embolic device 10 to exit the lumen 24 of the sheath 14. Without the sheath 14 maintaining the aneurysm embolic device 10 in a compressed configuration, the sealing member 30 and occlusive member 38 expand within the aneurysm 34. The thin circular membranes 54 of the sealing member 30 contact the wall of the aneurysm 34 and form a generally fluid tight seal.
  • FIG. 6 illustrates fluid pressure being applied to the lumen 16 of the deployment catheter 12 thereby causing the headpiece 28 of the aneurysm embolic device 10 to exit the distal end 26 of the deployment catheter 12. The expanded occlusive member 38 holds the sealing member 30 in position, and blood is generally prevented from flowing into the aneurysm 34.
  • A novel system has been disclosed in which an aneurysm embolic device is used to occlude the flow of blood within an aneurysm. Although a preferred embodiment of the invention has been described, it is to be understood that various modifications may be made by those skilled in the art without departing from the scope of the present invention. For example, there are many variations and modifications of the occlusive member, including helically wound embolic coils or other types of vascular occlusive devices, such as balloons, radiopaque fluids, and liquid medications.
  • These and other modifications would be apparent to those having ordinary skill in the art to which this invention relates and are intended to be within the scope of the claims which follow.

Claims (11)

1. A catheter-based aneurysm embolic system for occluding the flow of blood in an aneurysm, said aneurysm embolic system comprising:
a deployment catheter having a lumen extending therethrough and having proximal and distal ends;
an aneurysm embolic device comprising an expandable sealing member which includes a circular joining member, a plurality of reinforcing spokes attached to said circular joining member and extending radially outward from said circular joining member, and a thin circular membrane bonded to said circular joining member and said reinforcing spokes and an occlusive member comprised of an expandable foam material carried by said sealing member, and a headpiece attached to the sealing member and retained by the distal end of said deployment catheter so that when said aneurysm embolic device is placed at the neck of an aneurysm said sealing member may be expanded to seal the neck of the aneurysm and simultaneously permit expansion of said occlusive member within the aneurysm to thereby substantially fill the aneurysm.
2. A catheter-based aneurysm embolic system as defined in claim 1, wherein said occlusive member is formed from a material such that when said occlusive member is released within the aneurysm the occlusive member expands to substantially fill the aneurysm.
3. A catheter-based aneurysm embolic system as defined in claim 2, wherein said sealing member is cupped shaped to form convex and concave sides.
4. A catheter-based aneurysm embolic system as defined in claim 3, wherein said occlusive member is carried by the concave side of said sealing member.
5. A catheter-based aneurysm embolic system as defined in claim 4, wherein said circular membrane is made from a blood-impermeable polymer material.
6. A catheter-based aneurysm embolic system for occluding the flow of blood in an aneurysm, said aneurysm embolic system comprising:
a deployment catheter having a lumen extending therethrough and having proximal and distal ends; and,
an aneurysm embolic device comprising an expandable sealing member, which generally takes the form of an expandable flexible disk, an expandable foam occlusive member carried by said sealing member, and a headpiece attached to the center of said sealing member and retained at the distal end of said deployment catheter so that when said aneurysm embolic device is placed at a mouth of an aneurysm said sealing member may be expanded to seal the mouth of the aneurysm and simultaneously permit expansion of said foam occlusive member within the aneurysm to substantially fill the aneurysm.
7. A catheter-based aneurysm embolic system as defined in claim 6, wherein said occlusive member is formed from a material such that when said occlusive member is released within the aneurysm the occlusive member expands to substantially fill the aneurysm.
8. A catheter-based aneurysm embolic system as defined in claim 6, wherein said sealing member is cupped shaped to form convex and concave sides.
9. A catheter-based aneurysm embolic system as defined in claim 8, wherein said occlusive member is carried by the concave side of said sealing member.
10. A catheter-based aneurysm embolic system as defined in claim 6, wherein said expandable sealing member is generally tubular shaped prior to expansion.
11. A catheter-based aneurysm embolic system as defined in claim 6, wherein said expandable sealing member is made from a blood-impermeable polymer material.
US11/452,852 2001-11-15 2006-06-13 Aneurysm embolic device with an occlusive member Abandoned US20060235464A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/452,852 US20060235464A1 (en) 2001-11-15 2006-06-13 Aneurysm embolic device with an occlusive member

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33548901P 2001-11-15 2001-11-15
US10/295,196 US7083632B2 (en) 2001-11-15 2002-11-15 Aneurysm embolic device with an occlusive member
US11/452,852 US20060235464A1 (en) 2001-11-15 2006-06-13 Aneurysm embolic device with an occlusive member

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/295,196 Division US7083632B2 (en) 2001-11-15 2002-11-15 Aneurysm embolic device with an occlusive member

Publications (1)

Publication Number Publication Date
US20060235464A1 true US20060235464A1 (en) 2006-10-19

Family

ID=23311989

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/295,196 Active 2027-03-08 US7083632B2 (en) 2001-11-15 2002-11-15 Aneurysm embolic device with an occlusive member
US11/452,852 Abandoned US20060235464A1 (en) 2001-11-15 2006-06-13 Aneurysm embolic device with an occlusive member

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/295,196 Active 2027-03-08 US7083632B2 (en) 2001-11-15 2002-11-15 Aneurysm embolic device with an occlusive member

Country Status (5)

Country Link
US (2) US7083632B2 (en)
EP (1) EP1316293B1 (en)
JP (1) JP4429589B2 (en)
AT (1) ATE355790T1 (en)
DE (1) DE60218607T2 (en)

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060282115A1 (en) * 2005-06-09 2006-12-14 Abrams Robert M Thin film vessel occlusion device
US20080140098A1 (en) * 2006-11-15 2008-06-12 Monica Kumar Anastomosis Balloon Configurations and device
US20080312679A1 (en) * 2007-06-13 2008-12-18 Cook Incorporated Occluding device
US20110208233A1 (en) * 2004-01-22 2011-08-25 Mcguckin Jr James F Device for preventing clot migration from left atrial appendage
US8142456B2 (en) 2008-04-21 2012-03-27 Nfocus Neuromedical, Inc. Braid-ball embolic devices
US8425548B2 (en) 2010-07-01 2013-04-23 Aneaclose LLC Occluding member expansion and then stent expansion for aneurysm treatment
US8636760B2 (en) 2009-04-20 2014-01-28 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US8906057B2 (en) 2010-01-04 2014-12-09 Aneuclose Llc Aneurysm embolization by rotational accumulation of mass
US8926681B2 (en) 2010-01-28 2015-01-06 Covidien Lp Vascular remodeling device
US8974487B2 (en) 2008-05-01 2015-03-10 Aneuclose Llc Aneurysm occlusion device
US9060886B2 (en) 2011-09-29 2015-06-23 Covidien Lp Vascular remodeling device
US9078658B2 (en) 2013-08-16 2015-07-14 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9089332B2 (en) 2011-03-25 2015-07-28 Covidien Lp Vascular remodeling device
US9095343B2 (en) 2005-05-25 2015-08-04 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9095342B2 (en) 2009-11-09 2015-08-04 Covidien Lp Braid ball embolic device features
US9138232B2 (en) 2011-05-24 2015-09-22 Aneuclose Llc Aneurysm occlusion by rotational dispensation of mass
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
US9179918B2 (en) 2008-07-22 2015-11-10 Covidien Lp Vascular remodeling device
US9204983B2 (en) 2005-05-25 2015-12-08 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9259337B2 (en) 2007-06-04 2016-02-16 Sequent Medical, Inc. Methods and devices for treatment of vascular defects
US9295571B2 (en) 2013-01-17 2016-03-29 Covidien Lp Methods and apparatus for luminal stenting
US9314248B2 (en) 2012-11-06 2016-04-19 Covidien Lp Multi-pivot thrombectomy device
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
US9393022B2 (en) 2011-02-11 2016-07-19 Covidien Lp Two-stage deployment aneurysm embolization devices
US9463105B2 (en) 2013-03-14 2016-10-11 Covidien Lp Methods and apparatus for luminal stenting
US9468442B2 (en) 2010-01-28 2016-10-18 Covidien Lp Vascular remodeling device
US9597087B2 (en) 2008-05-02 2017-03-21 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9629635B2 (en) 2014-04-14 2017-04-25 Sequent Medical, Inc. Devices for therapeutic vascular procedures
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US9918720B2 (en) 2009-11-05 2018-03-20 Sequent Medical Inc. Multiple layer filamentary devices for treatment of vascular defects
US9955976B2 (en) 2013-08-16 2018-05-01 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
EP3340894A4 (en) * 2015-08-24 2019-06-12 Neurvana Medical LLC Intrasacular occlusion devices methods processes and systems
US10478194B2 (en) 2015-09-23 2019-11-19 Covidien Lp Occlusive devices
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US10736758B2 (en) 2013-03-15 2020-08-11 Covidien Occlusive device
US11291453B2 (en) 2019-03-15 2022-04-05 Sequent Medical, Inc. Filamentary devices having a flexible joint for treatment of vascular defects
US11317921B2 (en) 2019-03-15 2022-05-03 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US11559309B2 (en) 2019-03-15 2023-01-24 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60042316D1 (en) * 1999-01-28 2009-07-16 Salviac Ltd CATHETER WITH EXPANDABLE END CUT
DE10327119A1 (en) * 2003-06-13 2004-12-30 Aventis Pharma Deutschland Gmbh Injection cap
US20070135907A1 (en) 2003-10-02 2007-06-14 The Regents Of The University Of California Stent with expandable foam
US20070203452A1 (en) * 2003-10-07 2007-08-30 Mehta Bharat A Platform Catheter
JP4744863B2 (en) * 2003-12-17 2011-08-10 コドマン・アンド・シャートレフ・インコーポレイテッド Activable and bioactive implantable medical device and method of use thereof
US20050137568A1 (en) * 2003-12-17 2005-06-23 Jones Donald K. Activatable bioactive implantable medical device and method of use
BE1016067A3 (en) 2004-06-03 2006-02-07 Frid Noureddine Luminal endoprosthesis FOR OBSTRUCTION OF ANEURYSM AND METHOD OF MANUFACTURING SUCH STENT.
ATE448737T1 (en) 2004-09-22 2009-12-15 Dendron Gmbh DEVICE FOR IMPLANTING MICROWL COILS
US7879064B2 (en) 2004-09-22 2011-02-01 Micro Therapeutics, Inc. Medical implant
CA2649702C (en) 2006-04-17 2014-12-09 Microtherapeutics, Inc. System and method for mechanically positioning intravascular implants
US8777979B2 (en) 2006-04-17 2014-07-15 Covidien Lp System and method for mechanically positioning intravascular implants
AU2007285800A1 (en) * 2006-08-17 2008-02-21 Nfocus Neuromedical, Inc. Isolation devices for the treatment of aneurysms
KR20100015520A (en) 2007-03-13 2010-02-12 마이크로 테라퓨틱스 인코포레이티드 An implant including a coil and a stretch-resistant member
KR20100015521A (en) 2007-03-13 2010-02-12 마이크로 테라퓨틱스 인코포레이티드 An implant, a mandrel, and a method of forming an implant
US20100131002A1 (en) * 2008-11-24 2010-05-27 Connor Robert A Stent with a net layer to embolize and aneurysm
US20100280594A1 (en) * 2009-05-01 2010-11-04 Medi-Solve, Llc Antithrombotic Neurovascular Device Containing a Glycoprotein IIB/IIIA Receptor Inhibitor for The Treatment of Brain Aneurysms and/or Acute Ischemic Stroke, and Methods Related Thereto
EP3354210B1 (en) 2010-09-10 2022-10-26 Covidien LP Devices for the treatment of vascular defects
US8998947B2 (en) 2010-09-10 2015-04-07 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
CN104254285B (en) * 2011-11-09 2017-07-28 伊兹诺茨有限公司 Blocking device
US9579104B2 (en) 2011-11-30 2017-02-28 Covidien Lp Positioning and detaching implants
US9011480B2 (en) 2012-01-20 2015-04-21 Covidien Lp Aneurysm treatment coils
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
KR102309795B1 (en) 2012-11-13 2021-10-08 코비디엔 엘피 Occlusive devices
CN106456182B (en) 2013-12-20 2021-04-09 泰尔茂株式会社 Vascular occlusion device
US11076860B2 (en) 2014-03-31 2021-08-03 DePuy Synthes Products, Inc. Aneurysm occlusion device
US11154302B2 (en) 2014-03-31 2021-10-26 DePuy Synthes Products, Inc. Aneurysm occlusion device
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
US10736730B2 (en) 2015-01-20 2020-08-11 Neurogami Medical, Inc. Vascular implant
US11484319B2 (en) 2015-01-20 2022-11-01 Neurogami Medical, Inc. Delivery system for micrograft for treating intracranial aneurysms
JP6763864B2 (en) 2015-01-20 2020-09-30 ニューロガミ メディカル インコーポレイテッド Micrografts and usage for the treatment of intracranial aneurysms
US10857012B2 (en) 2015-01-20 2020-12-08 Neurogami Medical, Inc. Vascular implant
US10925611B2 (en) 2015-01-20 2021-02-23 Neurogami Medical, Inc. Packaging for surgical implant
US9375333B1 (en) 2015-03-06 2016-06-28 Covidien Lp Implantable device detachment systems and associated devices and methods
EP3253305B1 (en) * 2015-03-26 2020-07-22 Boston Scientific Scimed, Inc. Systems for vascular occlusion
JP7144404B2 (en) 2016-05-26 2022-09-29 ナノストラクチャーズ・インコーポレイテッド Systems and methods for embolic embolization of neural aneurysms
US10420563B2 (en) 2016-07-08 2019-09-24 Neurogami Medical, Inc. Delivery system insertable through body lumen
US10478195B2 (en) 2016-08-04 2019-11-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
CN110545739A (en) 2017-02-23 2019-12-06 德普伊新特斯产品公司 aneurysm devices and delivery systems
US10675036B2 (en) 2017-08-22 2020-06-09 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US10905430B2 (en) 2018-01-24 2021-02-02 DePuy Synthes Products, Inc. Aneurysm device and delivery system
EP3745965A4 (en) * 2018-01-31 2021-10-27 Nanostructures, Inc. Vascular occlusion devices utilizing thin film nitinol foils
US11058430B2 (en) 2018-05-25 2021-07-13 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11596412B2 (en) 2018-05-25 2023-03-07 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US10939915B2 (en) 2018-05-31 2021-03-09 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11051825B2 (en) 2018-08-08 2021-07-06 DePuy Synthes Products, Inc. Delivery system for embolic braid
US11123077B2 (en) 2018-09-25 2021-09-21 DePuy Synthes Products, Inc. Intrasaccular device positioning and deployment system
US11076861B2 (en) 2018-10-12 2021-08-03 DePuy Synthes Products, Inc. Folded aneurysm treatment device and delivery method
WO2020093012A1 (en) 2018-11-01 2020-05-07 Terumo Corporation Occlusion systems
US11406392B2 (en) 2018-12-12 2022-08-09 DePuy Synthes Products, Inc. Aneurysm occluding device for use with coagulating agents
CN111388045A (en) 2018-12-17 2020-07-10 柯惠有限合伙公司 Occlusion device
US11272939B2 (en) 2018-12-18 2022-03-15 DePuy Synthes Products, Inc. Intrasaccular flow diverter for treating cerebral aneurysms
US11134953B2 (en) 2019-02-06 2021-10-05 DePuy Synthes Products, Inc. Adhesive cover occluding device for aneurysm treatment
US11337706B2 (en) 2019-03-27 2022-05-24 DePuy Synthes Products, Inc. Aneurysm treatment device
US11672542B2 (en) 2019-05-21 2023-06-13 DePuy Synthes Products, Inc. Aneurysm treatment with pushable ball segment
US11602350B2 (en) 2019-12-05 2023-03-14 DePuy Synthes Products, Inc. Intrasaccular inverting braid with highly flexible fill material
US11607226B2 (en) 2019-05-21 2023-03-21 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device with corrugations
US11413046B2 (en) 2019-05-21 2022-08-16 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US11278292B2 (en) 2019-05-21 2022-03-22 DePuy Synthes Products, Inc. Inverting braided aneurysm treatment system and method
US10653425B1 (en) 2019-05-21 2020-05-19 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US11497504B2 (en) 2019-05-21 2022-11-15 DePuy Synthes Products, Inc. Aneurysm treatment with pushable implanted braid
US11504816B2 (en) 2019-11-04 2022-11-22 Covidien Lp Systems and methods for treating aneurysms
US11457926B2 (en) 2019-12-18 2022-10-04 DePuy Synthes Products, Inc. Implant having an intrasaccular section and intravascular section
US11931041B2 (en) 2020-05-12 2024-03-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693067A (en) * 1992-09-02 1997-12-02 Board Of Regents, The University Of Texas System Intravascular device
US5823198A (en) * 1996-07-31 1998-10-20 Micro Therapeutics, Inc. Method and apparatus for intravasculer embolization
US7128736B1 (en) * 1998-09-04 2006-10-31 Boston Scientific Scimed, Inc. Detachable aneurysm neck closure patch

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641692A1 (en) 1989-01-17 1990-07-20 Nippon Zeon Co Plug for closing an opening for a medical application, and device for the closure plug making use thereof
US5192290A (en) * 1990-08-29 1993-03-09 Applied Medical Resources, Inc. Embolectomy catheter
US5334210A (en) * 1993-04-09 1994-08-02 Cook Incorporated Vascular occlusion assembly
US6171329B1 (en) 1994-12-19 2001-01-09 Gore Enterprise Holdings, Inc. Self-expanding defect closure device and method of making and using
US5582619A (en) * 1995-06-30 1996-12-10 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils
US5645566A (en) * 1995-09-15 1997-07-08 Sub Q Inc. Apparatus and method for percutaneous sealing of blood vessel punctures
US6168622B1 (en) 1996-01-24 2001-01-02 Microvena Corporation Method and apparatus for occluding aneurysms
US5733294A (en) 1996-02-28 1998-03-31 B. Braun Medical, Inc. Self expanding cardiovascular occlusion device, method of using and method of making the same
EP0900051A1 (en) * 1996-05-08 1999-03-10 Salviac Limited An occluder device
US5951599A (en) 1997-07-09 1999-09-14 Scimed Life Systems, Inc. Occlusion system for endovascular treatment of an aneurysm
US5928260A (en) 1997-07-10 1999-07-27 Scimed Life Systems, Inc. Removable occlusion system for aneurysm neck
JP4060528B2 (en) * 1997-08-04 2008-03-12 ボストン サイエンティフィック コーポレーション Occlusion system for aneurysm treatment
DE69834920T2 (en) 1997-08-05 2007-05-24 Boston Scientific Ltd., St. Michael REMOVABLE SYSTEM FOR CLOSING AN ANEURYSMAS NECK
US6063070A (en) 1997-08-05 2000-05-16 Target Therapeutics, Inc. Detachable aneurysm neck bridge (II)
US6036720A (en) 1997-12-15 2000-03-14 Target Therapeutics, Inc. Sheet metal aneurysm neck bridge
US6183491B1 (en) 1998-03-10 2001-02-06 Cordis Corporation Embolic coil deployment system with improved embolic coil
US6113622A (en) 1998-03-10 2000-09-05 Cordis Corporation Embolic coil hydraulic deployment system
US6063100A (en) * 1998-03-10 2000-05-16 Cordis Corporation Embolic coil deployment system with improved embolic coil
US6063111A (en) 1998-03-31 2000-05-16 Cordis Corporation Stent aneurysm treatment system and method
US6165193A (en) 1998-07-06 2000-12-26 Microvention, Inc. Vascular embolization with an expansible implant
US6254612B1 (en) 1998-10-22 2001-07-03 Cordis Neurovascular, Inc. Hydraulic stent deployment system
US6428558B1 (en) 1999-03-10 2002-08-06 Cordis Corporation Aneurysm embolization device
US6309367B1 (en) * 1999-07-23 2001-10-30 Neurovasx, Inc. Aneurysm shield
US6652555B1 (en) 1999-10-27 2003-11-25 Atritech, Inc. Barrier device for covering the ostium of left atrial appendage
US6214029B1 (en) 2000-04-26 2001-04-10 Microvena Corporation Septal defect occluder

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693067A (en) * 1992-09-02 1997-12-02 Board Of Regents, The University Of Texas System Intravascular device
US5823198A (en) * 1996-07-31 1998-10-20 Micro Therapeutics, Inc. Method and apparatus for intravasculer embolization
US7128736B1 (en) * 1998-09-04 2006-10-31 Boston Scientific Scimed, Inc. Detachable aneurysm neck closure patch

Cited By (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110208233A1 (en) * 2004-01-22 2011-08-25 Mcguckin Jr James F Device for preventing clot migration from left atrial appendage
US9095343B2 (en) 2005-05-25 2015-08-04 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US10322018B2 (en) 2005-05-25 2019-06-18 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9381104B2 (en) 2005-05-25 2016-07-05 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US10064747B2 (en) 2005-05-25 2018-09-04 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9198666B2 (en) 2005-05-25 2015-12-01 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9204983B2 (en) 2005-05-25 2015-12-08 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US20060282115A1 (en) * 2005-06-09 2006-12-14 Abrams Robert M Thin film vessel occlusion device
US20080140098A1 (en) * 2006-11-15 2008-06-12 Monica Kumar Anastomosis Balloon Configurations and device
US9259337B2 (en) 2007-06-04 2016-02-16 Sequent Medical, Inc. Methods and devices for treatment of vascular defects
US11179159B2 (en) 2007-06-04 2021-11-23 Sequent Medical, Inc. Methods and devices for treatment of vascular defects
US20080312679A1 (en) * 2007-06-13 2008-12-18 Cook Incorporated Occluding device
US9017362B2 (en) * 2007-06-13 2015-04-28 Cook Medical Technologies Llc Occluding device
US8142456B2 (en) 2008-04-21 2012-03-27 Nfocus Neuromedical, Inc. Braid-ball embolic devices
US9039726B2 (en) 2008-04-21 2015-05-26 Covidien Lp Filamentary devices for treatment of vascular defects
US8747597B2 (en) 2008-04-21 2014-06-10 Covidien Lp Methods for making braid-ball occlusion devices
US8696701B2 (en) 2008-04-21 2014-04-15 Covidien Lp Braid-ball embolic devices
US9585669B2 (en) 2008-04-21 2017-03-07 Covidien Lp Multiple layer filamentary devices for treatment of vascular defects
US11844528B2 (en) 2008-04-21 2023-12-19 Covidien Lp Multiple layer filamentary devices for treatment of vascular defects
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US8974487B2 (en) 2008-05-01 2015-03-10 Aneuclose Llc Aneurysm occlusion device
US10610231B2 (en) 2008-05-02 2020-04-07 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9597087B2 (en) 2008-05-02 2017-03-21 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US10610389B2 (en) 2008-05-13 2020-04-07 Covidien Lp Braid implant delivery systems
US11707371B2 (en) 2008-05-13 2023-07-25 Covidien Lp Braid implant delivery systems
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US9179918B2 (en) 2008-07-22 2015-11-10 Covidien Lp Vascular remodeling device
US8636760B2 (en) 2009-04-20 2014-01-28 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9918720B2 (en) 2009-11-05 2018-03-20 Sequent Medical Inc. Multiple layer filamentary devices for treatment of vascular defects
US9095342B2 (en) 2009-11-09 2015-08-04 Covidien Lp Braid ball embolic device features
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
US8906057B2 (en) 2010-01-04 2014-12-09 Aneuclose Llc Aneurysm embolization by rotational accumulation of mass
US8926681B2 (en) 2010-01-28 2015-01-06 Covidien Lp Vascular remodeling device
US9468442B2 (en) 2010-01-28 2016-10-18 Covidien Lp Vascular remodeling device
US8425548B2 (en) 2010-07-01 2013-04-23 Aneaclose LLC Occluding member expansion and then stent expansion for aneurysm treatment
US9393022B2 (en) 2011-02-11 2016-07-19 Covidien Lp Two-stage deployment aneurysm embolization devices
US10004511B2 (en) 2011-03-25 2018-06-26 Covidien Lp Vascular remodeling device
US9089332B2 (en) 2011-03-25 2015-07-28 Covidien Lp Vascular remodeling device
US11147563B2 (en) 2011-03-25 2021-10-19 Covidien Lp Vascular remodeling device
US9138232B2 (en) 2011-05-24 2015-09-22 Aneuclose Llc Aneurysm occlusion by rotational dispensation of mass
US10828182B2 (en) 2011-09-29 2020-11-10 Covidien Lp Vascular remodeling device
US9060886B2 (en) 2011-09-29 2015-06-23 Covidien Lp Vascular remodeling device
US11654037B2 (en) 2011-09-29 2023-05-23 Covidien Lp Vascular remodeling device
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
US9877856B2 (en) 2012-07-18 2018-01-30 Covidien Lp Methods and apparatus for luminal stenting
US11406405B2 (en) 2012-11-06 2022-08-09 Covidien Lp Multi-pivot thrombectomy device
US9924959B2 (en) 2012-11-06 2018-03-27 Covidien Lp Multi-pivot thrombectomy device
US9314248B2 (en) 2012-11-06 2016-04-19 Covidien Lp Multi-pivot thrombectomy device
US9901472B2 (en) 2013-01-17 2018-02-27 Covidien Lp Methods and apparatus for luminal stenting
US9295571B2 (en) 2013-01-17 2016-03-29 Covidien Lp Methods and apparatus for luminal stenting
US9463105B2 (en) 2013-03-14 2016-10-11 Covidien Lp Methods and apparatus for luminal stenting
US10736758B2 (en) 2013-03-15 2020-08-11 Covidien Occlusive device
US11389309B2 (en) 2013-03-15 2022-07-19 Covidien Lp Occlusive device
US9295473B2 (en) 2013-08-16 2016-03-29 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US10136896B2 (en) 2013-08-16 2018-11-27 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9078658B2 (en) 2013-08-16 2015-07-14 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US10939914B2 (en) 2013-08-16 2021-03-09 Sequent Medical, Inc. Filamentary devices for the treatment of vascular defects
US9492174B2 (en) 2013-08-16 2016-11-15 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US11723667B2 (en) 2013-08-16 2023-08-15 Microvention, Inc. Filamentary devices for treatment of vascular defects
US10813645B2 (en) 2013-08-16 2020-10-27 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9955976B2 (en) 2013-08-16 2018-05-01 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9198670B2 (en) 2013-08-16 2015-12-01 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US11678886B2 (en) 2014-04-14 2023-06-20 Microvention, Inc. Devices for therapeutic vascular procedures
US9629635B2 (en) 2014-04-14 2017-04-25 Sequent Medical, Inc. Devices for therapeutic vascular procedures
EP3340894A4 (en) * 2015-08-24 2019-06-12 Neurvana Medical LLC Intrasacular occlusion devices methods processes and systems
US11357510B2 (en) 2015-09-23 2022-06-14 Covidien Lp Occlusive devices
US10478194B2 (en) 2015-09-23 2019-11-19 Covidien Lp Occlusive devices
US11559309B2 (en) 2019-03-15 2023-01-24 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US11317921B2 (en) 2019-03-15 2022-05-03 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US11291453B2 (en) 2019-03-15 2022-04-05 Sequent Medical, Inc. Filamentary devices having a flexible joint for treatment of vascular defects

Also Published As

Publication number Publication date
JP4429589B2 (en) 2010-03-10
DE60218607T2 (en) 2007-11-08
EP1316293A3 (en) 2003-12-10
DE60218607D1 (en) 2007-04-19
JP2003190292A (en) 2003-07-08
US20030093097A1 (en) 2003-05-15
US7083632B2 (en) 2006-08-01
ATE355790T1 (en) 2007-03-15
EP1316293A2 (en) 2003-06-04
EP1316293B1 (en) 2007-03-07

Similar Documents

Publication Publication Date Title
US7083632B2 (en) Aneurysm embolic device with an occlusive member
US7195636B2 (en) Aneurysm neck cover for sealing an aneurysm
JP6110427B2 (en) System and method for sealing an anatomical opening
JP4447175B2 (en) Embolization device for aneurysms inserted into blood vessels
US6254612B1 (en) Hydraulic stent deployment system
EP1750619B1 (en) Flexible vascular occluding device
US7695488B2 (en) Expandable body cavity liner device
US7232461B2 (en) Neck covering device for an aneurysm
US8398700B2 (en) Intravascular flow modifier and reinforcement device and deployment system for same
US6811560B2 (en) Stent aneurysm embolization method and device
EP1006890B1 (en) Occlusion system for aneurysm repair
US6139564A (en) Minimally occlusive flow disruptor stent for bridging aneurysm necks
US20040172056A1 (en) Bifurcated aneurysm buttress arrangement
US20030181927A1 (en) Aneurysm neck obstruction device
US20030083676A1 (en) Aneurysm neck obstruction device
JP2009512515A (en) Methods and systems for clipping within a vessel and repairing intraluminal and tissue defects.
JP6195817B2 (en) Method and system for clipping intravascular and repairing intracavitary and tissue defects
US20060085028A1 (en) Vessel occlusion system
US20220183695A1 (en) Occluding medical devices and methods of use

Legal Events

Date Code Title Description
AS Assignment

Owner name: CODMAN & SHURTLEFF, INC., MASSACHUSETTS

Free format text: MERGER;ASSIGNOR:CORDIS NEUROVASCULAR, INC.;REEL/FRAME:023032/0233

Effective date: 20081216

Owner name: CODMAN & SHURTLEFF, INC.,MASSACHUSETTS

Free format text: MERGER;ASSIGNOR:CORDIS NEUROVASCULAR, INC.;REEL/FRAME:023032/0233

Effective date: 20081216

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION

AS Assignment

Owner name: DEPUY SYNTHES PRODUCTS, LLC, MASSACHUSETTS

Free format text: CHANGE OF NAME;ASSIGNOR:HAND INNOVATIONS LLC;REEL/FRAME:030341/0721

Effective date: 20121231

Owner name: DEPUY SPINE, INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CODMAN & SHURTLEFF, INC.;REEL/FRAME:030341/0689

Effective date: 20121230

Owner name: HAND INNOVATIONS LLC, FLORIDA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DEPUY SPINE, LLC;REEL/FRAME:030341/0713

Effective date: 20121230

AS Assignment

Owner name: DEPUY SPINE, LLC, MASSACHUSETTS

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME PREVIOUSLY RECORDED AT REEL: 030341 FRAME: 0689. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:CODMAN & SHURTLEFF, INC.;REEL/FRAME:033684/0122

Effective date: 20121230